Federal Register / Vol. 65, No. 28 / Thursday, February 10, 2000 / Notices 6633

objectives of the venture. The

notifications were filed for the purpose

of invoking the Act’s provisions limiting

the recovery of antitrust plaintiffs to

actual damages under specified

circumstances. Pursuant to Section 6(b)

of the Act, the identities of the parties

are Nonlinear Dynamics Incorporated

(NDI), Ann Arbor, MI; and UOP LLC,

Des Plaines, IL. The nature and

objectives of the venture are to conduct

research for ‘‘Combinatorial Tools and

Advanced Data Analysis Methods for

Heterogeneous Catalysis’’.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 00–3126 Filed 2–9–00; 8:45 am]

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—VSI Alliance

Notice is hereby given that, on April

20, 1999, pursuant to section 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), VSI Alliance has

filed written notifications

simultaneously with the Attorney

General and the Federal Trade

Commission disclosing changes in its

membership status. The notifications

were filed for the purpose of extending

the Act’s provisions limiting the

recovery of antitrust plaintiffs to actual

damages under specified circumstances.

Specifically, Prakash Bare (individual

membership), San Jose, CA; EnThink,

Inc., Santa Clara, CA; Hantro Products

Oy, Oulu, FINLAND; Korea Electronic

Technology Institute, Pyung Taek-Si,

Kyung Gi-Do, SOUTH KOREA;

Massana, Inc., Campbell, CA; TAEUS,

Colorado Springs, CO; The Silicon

Group, Inc., Austin, TX; and Worldwide

Semiconductor Manufacturing Corp.,

Hsinchu, TAIWAN have been added as

parties to this venture. Also, Ambit

Design Systems, Inc., Austin, TX;

Beijing Intelligent Electronics Co., Ltd.,

Beijing, PEOPLES REPUBLIC OF

CHINA; CAE Plus, Inc., Austin, TX;

Cygnus Solutions, Sunnyvale, CA; Duet

Technologies, Inc., San Jose, CA;

Exemplar Logic, Inc., Fremont, CA; FFC

Limited (Fuji Facom Control), Tokyo,

JAPAN; Lockheed Martin Advanced

Technology Labs, Camden, NJ; LTX

Corp., Westwood, MA; Neuw

Intellectual Property, Oldham, Lancs.,

UNITED KINGDOM; SIS

Microelectronics, Inc., Longmont, CO;

Spinnaker Systems, Inc., Tokyo, JAPAN;

Vantis, Sunnyvale, CA; Wipro Ltd.,

Santa Clara, CA; and Yokogawa Electric

Corp., Tokyo, JAPAN have been

dropped as parties to this venture.

No other changes have been made in

either the membership or planned

activity of the group research project.

Membership in this group research

project remains open, and VSI Alliance

intends to file additional written

notification disclosing all changes in

membership.

On November 29, 1996, VSI Alliance

filed its original notification pursuant to

Section 6(a) of the Act. The Department

of Justice published a notice in the

Federal Register pursuant to Section

6(b) of the Act on March 4, 1997 (62 FR

9812).

The last notification was filed with

the Department on February 11, 1999. A

notice has not yet been published in the

Federal Register.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 00–3123 Filed 2–9–00; 8:45 am]

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated October 8, 1999, and

published in the Federal Register on

October 18, 1999, (64 FR 56225),

Cedarburg Laboratories, Inc., 870 Badger

Circle, Grafton, Wisconsin 53024, made

application by letter to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

propiram (9649), a basic class of

controlled substance listed in Schedule

I.

The firm will manufacture propiram

in the process of manufacturing other

targeted test compounds for another

firm.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Cedarburg Laboratories,

Inc. to manufacture propiram is

consistent with the public interest at

this time. DEA has investigated the

company to ensure that the company’s

registration is coninspection and testing

of the company’s physical security

systems, verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to 21 U.S.C. 823 and 28 CFR

0.100 and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic class of controlled substance

listed above is granted.

Dated: February 4, 2000.

John H. King,

Deputy, Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–3142 Filed 2–9–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated October 1, 1999, and

published in the Federal Register on

October 13, 1999, (64 FR 55489),

Chattem Chemicals, Inc., 3801 St. Elmo

Avenue, Building 18, Chatanooga,

Tennessee 37409, made application by

renewal to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of

methamphetamine (1105), a basic class

of controlled substance listed Schedule

II.

The firm plans to bulk manufacture

methamphetamine to produce products

for distribution to its customers.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Chattem Chemicals, Inc.

to manufacture methamphetamine is

consistent with the public interest at

this time. DEA has investigated the firm

on a regular basis to ensure that the

company’s continued registration is

consistent with the public interest.

These investigations have included

inspection and testing of the company’s

physical security systems, verification

of the company’s compliance with state

and local laws, and a review of the

company’s background and history.

Therefore, pursuant to 21 U.S.C. 823

and 28 CFR § 0.100 and 0.104, the

Deputy Assistant Administrator, Office

of Diversion Control, hereby orders that

the application submitted by the above

firm for registration as a bulk

manufacturer of the basic class of

controlled substance listed above is

granted.

Dated: January 24, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–3143 Filed 2–9–00; 8:45 am]

BILLING CODE 4410–09–M